Nastorazepide

• Target :

  HIF/HIF Prolyl-Hydroxylase|||Ephrin Receptor|||VEGFR|||Akt|||Cholecystokinin Receptor|||Interleukin

• Related Pathways :

  Cytoskeletal Signaling|||Metabolism|||GPCR/G Protein|||Tyrosine Kinase/Adaptors|||PI3K/Akt/mTOR signaling|||Angiogenesis|||Immunology/Inflammation|||Chromatin/Epigenetic

• Purity :

  0.9983

• Bioactivity :

  Nastorazepide (Z-360) is a selective, orally available antagonist of the gastrin/cholecystokinin 2 (CCK-2) receptor with potential antineoplastic activity.

• Smiles :

  CC(C)(C)C(=O)CN1c2ccccc2N(C[C@@H](NC(=O)Nc2cccc(c2)C(O)=O)C1=O)C1CCCCC1

• Molecular Formula :

  C29H36N4O5

• Molecular Weight :

  520.62

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  209219-38-5